Insurance companies in the spotlight as Hurricane Idalia makes landfall in Florida as a Category 3 storm
By Steve Gelsi
Allstate, Willis Tower Watson, Renaissance Re and Arch Capital Group lead gains among insurers.
Stocks with exposure to the insurance and reinsurance businesses rose Wednesday as Hurricane Idalia made landfall in Florida's Big Bend region on the Gulf of Mexico and caused widespread flooding, but missed any major population center as it came to shore.
Hurricane Idalia made landfall at around 7:45 a.m. Eastern Time on the coast of the Florida Big Bend near Keaton Beach, according to the National Hurricane Center.
The storm hit the coast as a Category 3 storm with winds near 125 mph as it weakened from a Category 4.
Most publicly traded companies active in the insurance sector moved higher.
Swiss Re dipped 0.3%, while Aon Plc (AON) rose 0.5%, Allstate (ALL) rose 1%, Travelers (TRV) rose by 0.3%, Everest Group (EG) rose 1.5%, Willis Towers Watson (WTW) moved up by 0.9% and Arthur Gallagher (AJG) rose by 0.5%.
Progressive (PGR) rose 0.8%, Chubb Ltd. (CB) rose 0.3%, Hanover Insurance Group (THG) rose by 0.6%, Renaissance Re (RNR) moved up by 1.7% and Arch Capital Group (ACGL) advanced by 1.3%.
Also read:Travelers swings to loss as it books $1.5 billion in catastrophe losses following tornadoes and hail storms
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-30-23 1012ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth